|
Symbol
|
ABRITQ | ABSRTQ | DLDCBL | ACHDTQ | AEGJTQ |
|---|---|---|---|---|---|
| Name | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible |
|
Underlying
|
CRISPR Therapeutics AG / Lonza Group N / Novartis AG | CRISPR Therapeutics AG / Roche AG / Sonova Hldg. AG | Bachem Hldg. AG / CRISPR Therapeutics AG / Straumann Hldg. AG | CRISPR Therapeutics AG / Novartis AG / Roche AG | CRISPR Therapeutics AG / Lonza Group N / Ypsomed Hldg. AG |
|
Issuer
|
|
|
|
|
|
|
Date of maturity
|
10.06.2026 | 17.06.2026 | 22.07.2026 | 04.09.2026 | 09.12.2026 |
| Bid | - | 100.60 | - | - | 92.80 |
| Ask | - | 101.41 | - | - | 93.60 |